Benzinga.com

LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress

Holding company Blackhawk Growth Corp.BLRZF's subsidiary company MindBio Therapeutics Pty Ltd shared the positive data gathered from its Phase 1 clinical trials microdosing LSD formulation in 80 ...
WRAL

A woman took 550 times the usual dose of LSD, with surprisingly positive consequences

Drug overdoses can be life threatening, but for two women who accidentally took massive hits of LSD the experience was life changing -- and in a good way. A 46-year-old woman snorted a staggering 550 ...
PsyPost on MSN

LSD microdosing linked to acute mood improvements in adults with depression

Taking tiny, frequent amounts of the psychedelic drug lysergic acid diethylamide (LSD) might temporarily elevate mood for people diagnosed with major depressive disorder. In a small pilot study, ...
MarketWatch

MindMed stock jumps 4.5% after psychedelics company reports positive findings in trial of LSD as treatment for major depressive disorder

The stock of psychedelics company Mind Medicine Inc. MNMD rose 4% Friday, after the company’s Swiss research partners reported positive results from a Phase 2 trial of LSD as a treatment for major ...
Hosted on MSN

Swiss study finds LSD, psilocybin therapy eases severe depression

Real-world results: Swiss hospitals saw strong mental health improvements in patients given LSD or psilocybin with psychotherapy under a compassionate use program. Safe in clinics: No serious side ...
GEN

Licit Activity: MindMed Collaborators Announce Positive Phase II Results for LSD in Major Depressive Disorder

April 14, 2023, is “bicycle day” in Switzerland, a day that commemorates Dr. Albert Hofmann intentionally taking lysergide—more commonly known as LSD (lysergic acid diethylamide)—for the first time in ...
Benzinga.com

LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood Issues

MindBio Therapeutics obtained approvals for clinical trials in women’s health using its proprietary LSD drug, MB22001. MB22001 aims to address a huge unmet need in the ~25% of women who experience PMS ...
MarketWatch

MindMed’s stock boosted by positive data in trial of LSD as treatment for anxiety disorder

Mind Medicine Inc.’ stock surged 6.5% Thursday, after the company said a Phase 2 trial testing LSD as a treatment for generalized anxiety disorder met its main goal, showing a statistically ...
Business Wire

MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel products to treat brain ...
Cleveland.com

LSD to treat severe anxiety? Cleveland Clinic at forefront of psychedelic research

CLEVELAND, Ohio — The Cleveland Clinic is in the vanguard of a new era of research into psychedelic medicine. The Clinic is the only Ohio site participating in a national study looking at whether LSD, ...
Medical News Today

LSD-like compounds may have antidepressant effect without hallucinations

Previous studies have shown that the hallucinogenic effects of LSD are mediated to a large extent by the signaling pathway involving the β-arrestin-2 protein. Thus, it is possible that compounds that ...